Pfizer Inc.(PFE)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
PFE | 158.56 B | 37.09x | 2.60% | 6.80% | $0.75 | 5.01% | 0.74x | 6.12% | $29.21 | $23.62 |
LLY | 1.04 T | 39.58x | 47.70% | 33.53% | $29.55 | 102.29% | 1.62x | 0.56% | $1292.65 | $778.94 |
JNJ | 618.09 B | 30.42x | 6.60% | 21.48% | $8.43 | 25.74% | 0.58x | 2.03% | $281.07 | $178.91 |
ABBV | 481.40 B | 77.61x | 10.20% | 9.80% | $3.51 | - | - | 2.63% | $269.39 | $189.40 |
AZN | 246.25 B | 23.77x | 6.40% | 17.02% | $6.68 | 21.97% | 0.64x | 2.05% | $210.52 | $153.41 |
NVO | 127.55 B | 9.69x | 2.10% | 35.35% | $3.94 | 59.82% | 0.63x | 31.28% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Pfizer Inc. (PFE) compared to its primary competitors (including LLY, JNJ, ABBV) reveals distinct metrics. PFE trades roughly in line with its competitors, with a P/E ratio of 37.1x versus the peer average of 36.7x, reflecting valuation parity within the industry. In terms of growth, PFE's revenue growth of 2.6% lags behind the peer average of 12.7%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 6.8% is below the peer average of 20.9%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• PFE ranks #3 in P/E ratio, #5 in revenue growth, and #5 in profit margins
• Average ranking: #4 - ⚠️ Room for improvement relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-08 | $27.90 | $28.00 | $27.48 | $27.82 | 44,322,600 | -0.64% |
| 2026-10-07 | $27.62 | $28.17 | $27.55 | $28.00 | 31,230,400 | +1.82% |
| 2026-10-06 | $27.48 | $27.71 | $27.20 | $27.50 | 24,066,100 | +0.33% |
| 2026-10-05 | $27.65 | $27.72 | $27.12 | $27.41 | 33,005,400 | -1.40% |
| 2026-10-02 | $28.15 | $28.16 | $27.44 | $27.80 | 35,007,900 | -1.14% |
| 2026-10-01 | $28.45 | $28.59 | $28.08 | $28.12 | 30,494,200 | -1.40% |
| 2026-09-30 | $28.79 | $28.95 | $28.52 | $28.52 | 33,629,100 | -0.70% |
| 2026-09-29 | $28.60 | $28.76 | $28.26 | $28.72 | 33,304,600 | +0.00% |
| 2026-09-28 | $28.62 | $28.87 | $28.39 | $28.72 | 24,950,500 | +0.17% |
| 2026-09-25 | $28.45 | $28.69 | $28.17 | $28.67 | 27,755,200 | +0.92% |
| 2026-09-24 | $28.20 | $28.85 | $28.20 | $28.41 | 34,774,700 | +0.82% |
| 2026-09-23 | $27.96 | $28.23 | $27.84 | $28.18 | 33,812,900 | +0.90% |
| 2026-09-22 | $27.74 | $28.00 | $27.49 | $27.93 | 26,663,500 | +0.68% |
| 2026-09-21 | $27.65 | $27.92 | $27.53 | $27.74 | 28,769,800 | +0.29% |
| 2026-09-18 | $27.64 | $27.66 | $27.34 | $27.66 | 75,593,400 | +0.07% |
Explore More Analysis for PFE
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.